Kurzbeschreibung
First ever comprehensive coverage of the pharmacokinetic and pharmacodynamic characteristics of highly important class of biology-based drugs. Spans all topics from lead identification right up to final-stage clinical trials -- a must for all pharmaceutical researchers.
Aus dem Inhalt
The Role of Pharmacokinetics and Pharmacodynamics in the Development of Biotech Drugs
Pharmacokinetics of Peptides and Proteins
Pharmacokinetics of Monoclonal Antibodies
Pharmacokinetics and Pharmacodynamics of Antisense Oligonucleotides
Pharmacokinetics of Viral and Non-Viral Gene Delivery Vectors
Bioanalytical Methods used for Pharmacokinetic Evaluations of Biotech Macromolecule Drugs: Issues, Assay Approaches, and Limitations
Limitations of Noncompartmental Pharmacokinetic Analysis of Biotech Drugs
Bioequivalence of Biologics
Biopharmaceutical Challenges in Pulmonary Delivery of Proteins and Peptides
Biopharmaceutical Challenges: Delivery of Oligonucleotides
Custom-Tailored Pharmacokinetics and Pharmacodynamics via Chemical Modifications of Biotech Drugs
Exposure?Response Relationships for Therapeutic Biologic Products
Preclinical and Clinical Drug Development of Tasidotin, a Depsi-Pentapeptide Oncolytic Agent
Clinical Drug Development of Cetuximab, a Monoclonal Antibody
Integration of Pharmacokinetics and Pharmacodynamics into the Drug Development of Pegfilgrastim, a Pegylated Protein
Search for this author
Statement of Responsibility:
edited by Bernd Meibohm
Year:
2006
Publisher:
Weinheim [u.a.], Wiley-VCH
Articles:
Go to this article
opens in new tab
Open this link in new tab
more...
ISBN:
3527314083
ISBN (2nd):
9783527314089
Description:
XXI, 403 S. : Ill., graph. Darst.
Language:
englisch||
Footnote:
Literaturangaben
Media group:
Ausleihbestand